Early skin tumor detection with telemedicine in primary care
Official title: Early Detection of Skin Tumors Using a Telemedicine Tool in Primary Care
Run by Institute of Health Information and Statistics of the Czech Republic · NCT07349940 · Data updated 2026-11-12
This project will test whether a telemedicine tool used by general practitioners can help detect suspicious skin lesions earlier in people with fair skin in the Czech Republic.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 50 Years and up |
| Sex | All |
| Enrollment | 1440 (estimated) |
| Sponsor | Institute of Health Information and Statistics of the Czech Republic Government |
| Locations | 5 sites (Brno and 4 other locations) |
| Status | Recruiting |
| Started | February 1, 2026 |
| Main results expected | August 31, 2026 |
| Study ends | January 30, 2027 |
| Registry record updated | November 4, 2026 |
| Trial ID | NCT07349940 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are people in the Czech Republic with at least one suspicious skin lesion, phototype I or II, who have not had a dermatologist skin examination in the past 12 months and can visit a participating GP site.
✕Probably not a fit
People with darker skin types (phototype III or higher), those without any suspicious lesions, or those already examined by a dermatologist within the last 12 months are unlikely to benefit from this pilot.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a national, prospective, multicenter, single-arm pilot that will train 18 general practitioners and link them with 6 dermatology centers to use a telemedicine tool for screening skin tumors. About 1,440 participants with at least one suspicious lesion and phototype I or II will have images and clinical data reviewed remotely by affiliated dermatologists. The project will develop a standardized methodology, set up workflows for GP–dermatologist collaboration, and test integration of the process into the health-care system. Findings will be used to propose system-level changes to improve screening efficiency and referral pathways.
Why it matters
Potential benefit: If successful, the project could enable earlier detection of skin cancers and more efficient referrals from primary care to dermatology, reducing delays and unnecessary in-person visits.
How similar studies have gone: Previous teledermatology studies have shown good diagnostic accuracy and improved access to dermatology care, though national-scale implementation pilots are less common.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * at least 1 suspected lession * phototype I or phototype II Exclusion Criteria: * skin lession examination by dermatologist in last 12 months * unsigned consent to participate in the project and consent to the processing of personal data
Where it's running
-
Olomouc University Hospital
Olomouc, Czechia Recruiting -
Bulovka University Hospital
Prague, Czechia Recruiting -
St. Anne's University Hospital Brno
Brno, Czechia Not yet recruiting -
University Hospital Pilsen
Pilsen, Czechia Not yet recruiting -
University hospital Kralovske Vinohrady
Prague, Czechia Not yet recruiting
Study contacts
- Study coordinator: Dagmar Obšilová, Msc
- Email: dagmar.obsilova@uzis.cz
- Phone: +420606429382
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Skin cancer self-detection education: does framing affect outcomes?
This trial tests a skin cancer education program to see if gain- or loss-framed messages help people with skin of color detect skin changes and adopt sun-protective behaviors.
-
Understanding diagnostic and prognostic factors in melanoma
This study is trying to find out how different types of skin growths, like melanoma and benign moles, affect patients by looking at their medical history and collecting blood samples.
-
AI tool helps dermatologists decide if a skin lesion could be melanoma
A computer tool called DEXI tested with DermaGraphix Visualizer helps dermatologists see if a skin lesion might be melanoma and aims to reduce unnecessary biopsies.
-
Mobile sun protection support to help young adults stay safe in the sun
This project tests a mobile health program to see if reminders, education, planning tools, and real-time sun exposure information can help young adults protect their skin from excessive sun exposure.
-
Sun Safe Together: a digital skin cancer prevention approach for teens and their parents
A small, single-arm trial will test whether a 12-week digital program using teen MMS messages and a private Facebook group for parents can feasibly and acceptably improve sun safety among adolescents and their parents.
-
Paraffin oil to protect skin from tourniquet damage during upper limb surgery
This trial will try applying topical paraffin oil to the skin of adults having elective upper extremity surgery to see if it prevents tourniquet-related redness, blisters, or abrasions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.